Pleiotropic effects of statins on the cardiovascular system

A Oesterle, U Laufs, JK Liao - Circulation research, 2017 - Am Heart Assoc
The statins have been used for 30 years to prevent coronary artery disease and stroke. Their
primary mechanism of action is the lowering of serum cholesterol through inhibiting hepatic …

Pleiotropic Effects of Statins–Basic Research and Clinical Perspectives–

Q Zhou, JK Liao - Circulation journal, 2010 - jstage.jst.go.jp
Figure 2. Regulation of the Rho GTPase cycle. Rho protein cycle between an inactive GDP-
bound and an active GTP-bound state. Inhibition of the mevalonate synthesis by statins …

MicroRNA-133 controls cardiac hypertrophy

A Care, D Catalucci, F Felicetti, D Bonci, A Addario… - Nature medicine, 2007 - nature.com
Growing evidence indicates that microRNAs (miRNAs or miRs) are involved in basic cell
functions and oncogenesis. Here we report that miR-133 has a critical role in determining …

Vascular endothelium dysfunction: a conservative target in metabolic disorders

S Jamwal, S Sharma - Inflammation Research, 2018 - Springer
Aim Vascular endothelium plays a role in capillary transport of nutrients and drugs and
regulates angiogenesis, homeostasis, as well as vascular tone and permeability as a major …

Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes

T Ago, J Kuroda, J Pain, C Fu, H Li… - Circulation …, 2010 - Am Heart Assoc
Rationale: NADPH oxidases are a major source of superoxide (O2−) in the cardiovascular
system. The function of Nox4, a member of the Nox family of NADPH oxidases, in the heart is …

Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy

Q Zhou, JK Liao - Current pharmaceutical design, 2009 - ingentaconnect.com
Statins are 3-hydroxy-3-methyglutaryl coenzyme A (HMG-CoA) reductase inhibitors, which
are prescribed extensively for cholesterol lowering in the primary and secondary prevention …

Pleiotropic effects of statins: new therapeutic targets in drug design

O Bedi, V Dhawan, PL Sharma, P Kumar - … -Schmiedeberg's archives of …, 2016 - Springer
The HMG Co-enzyme inhibitors and new lipid-modifying agents expand their new
therapeutic target options in the field of medical profession. Statins have been described as …

Rho kinases in health and disease: from basic science to translational research

G Loirand, RM Touyz - Pharmacological reviews, 2015 - Elsevier
Rho-associated kinases ROCK1 and ROCK2 are key regulators of actin cytoskeleton
dynamics downstream of Rho GTPases that participate in the control of important …

Diabetes-induced coronary vascular dysfunction involves increased arginase activity

MJ Romero, DH Platt, HE Tawfik, M Labazi… - Circulation …, 2008 - Am Heart Assoc
Increases in arginase activity have been reported in a variety of disease conditions
characterized by vascular dysfunction. Arginase competes with NO synthase for their …

Loss of chromosome 8p governs tumor progression and drug response by altering lipid metabolism

Y Cai, J Crowther, T Pastor, LA Asbagh, MF Baietti… - Cancer cell, 2016 - cell.com
Large-scale heterozygous deletions are a hallmark of cancer genomes. The concomitant
loss of multiple genes creates vulnerabilities that are impossible to reveal through the study …